Reduction in physician reimbursement and use of hormone therapy in prostate cancer
about
Pharmaceutical policies: effects of financial incentives for prescribersSecondary data analysis of large data sets in urology: successes and errors to avoid.Comparison of SEER Treatment Data With Medicare Claims.Improving care and reducing costs in oncologyUse of the Medicare database in epidemiologic and health services research: a valuable source of real-world evidence on the older and disabled populations in the US.Factors associated with geographic variation in cost per episode of care for three medical conditionsGonadotropin-releasing hormone agonist overuse: urologists' response to reimbursement and characteristics associated with persistent overuseSustainability and performance of the National Cancer Institute's Community Clinical Oncology ProgramProstate carcinogenesis with diabetes and androgen-deprivation-therapy-related diabetes: an updateMedical oncologists' perceptions of financial incentives in cancer care.Adoption of Intermittent Androgen Deprivation Therapy for Advanced Prostate Cancer: A Population Based Study in American Urology Practice.The relation between age and androgen deprivation therapy use among men in the Medicare population receiving radiation therapy for prostate cancerAre Small Reimbursement Changes Enough to Change Cancer Care? Reimbursement Variation in Prostate Cancer Treatment.Association Between the Number of Suppliers for Critical Antineoplastics and Drug Shortages: Implications for Future Drug Shortages and Treatment.Effect of financial relationships on the behaviors of health care professionals: a review of the evidence.Breast reconstruction national trends and healthcare implications.Trans-Pacific variation in outcomes for men treated with primary androgen-deprivation therapy (ADT) for prostate cancer.Trends in Antineoplastic Receipt after Medicare Payment Reform: Implications for Future Oncology Payment Design
P2860
Q24188018-70154163-88DE-4F73-AEB5-3A1E362A0C99Q30680391-C915A097-47C6-4628-9534-41D4326EAED5Q30779910-A755EDAE-3492-4152-8589-1566E9F5D027Q33629645-BD8226E8-EC16-40FE-8CB3-A293454ECB1CQ33693126-8C785A0B-C2BA-444B-984D-F0E6AB6C6DAAQ33737738-12CF7127-77C0-4160-9BEB-D8457FF07363Q35602510-BD02E949-1620-4276-9AF2-F6CB64E60557Q35661170-BDA428E8-B020-4961-9753-9ABFBB351455Q36076214-7C780233-C5F1-4A28-A416-B0FB4775FB8EQ36589617-57CE2FB6-9E25-4A4C-984C-690D3981E33EQ36623249-D0D7BE1B-FA46-4043-A12C-D884EF41C0EDQ36665817-ACA64CA3-A5AD-4DA2-9FD8-7E72F13E5506Q37125012-7B227417-A277-4AFA-9FA1-7B3FA1787673Q37125056-0DDA59FF-C059-49A5-8A05-82DFEC07AFE2Q38051676-5054C899-A604-4583-9128-E2AC4EA50E08Q39403706-A0C32F2F-8E6B-49A7-A8CF-A6E46DE2DE35Q46772110-0B70E55B-9A95-4526-9551-4D726A4917D7Q57822900-95767395-7BB0-4AD5-9A1C-9E57D0DD6C1C
P2860
Reduction in physician reimbursement and use of hormone therapy in prostate cancer
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Reduction in physician reimbursement and use of hormone therapy in prostate cancer
@ast
Reduction in physician reimbursement and use of hormone therapy in prostate cancer
@en
Reduction in physician reimbursement and use of hormone therapy in prostate cancer
@nl
type
label
Reduction in physician reimbursement and use of hormone therapy in prostate cancer
@ast
Reduction in physician reimbursement and use of hormone therapy in prostate cancer
@en
Reduction in physician reimbursement and use of hormone therapy in prostate cancer
@nl
prefLabel
Reduction in physician reimbursement and use of hormone therapy in prostate cancer
@ast
Reduction in physician reimbursement and use of hormone therapy in prostate cancer
@en
Reduction in physician reimbursement and use of hormone therapy in prostate cancer
@nl
P2093
P2860
P356
P1476
Reduction in physician reimbursement and use of hormone therapy in prostate cancer
@en
P2093
Beth A Virnig
Sean P Elliott
Stephanie L Jarosek
Timothy J Wilt
P2860
P304
P356
10.1093/JNCI/DJQ417
P407
P577
2010-12-03T00:00:00Z